FEATURED COMPANIES
- BD Biosciences
- GE Healthcare
- PerkinElmer, Inc.
- Takara Bio, Inc.
- TATAA Biocenter AB
- UK Stem Cell Bank
Global Human Embryonic Stem Cell (hESC) Research Market to Reach $1 Billion by 2027
Amid the COVID-19 crisis, the global market for Human Embryonic Stem Cell (hESC) Research estimated at US$650.9 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Regenerative Medicine, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$717.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Stem Cell Biology Research segment is readjusted to a revised 7.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $192.2 Million, While China is Forecast to Grow at 6.1% CAGR
The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$192.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$177.3 Million by the year 2027 trailing a CAGR of 6.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.
Tissue Engineering Segment to Record 5.1% CAGR
In the global Tissue Engineering segment, USA, Canada, Japan, China and Europe will drive the 5.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$39.3 Million in the year 2020 will reach a projected size of US$55.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$116.4 Million by the year 2027.
Select Competitors (Total 25 Featured):
Amid the COVID-19 crisis, the global market for Human Embryonic Stem Cell (hESC) Research estimated at US$650.9 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Regenerative Medicine, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$717.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Stem Cell Biology Research segment is readjusted to a revised 7.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $192.2 Million, While China is Forecast to Grow at 6.1% CAGR
The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$192.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$177.3 Million by the year 2027 trailing a CAGR of 6.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.
Tissue Engineering Segment to Record 5.1% CAGR
In the global Tissue Engineering segment, USA, Canada, Japan, China and Europe will drive the 5.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$39.3 Million in the year 2020 will reach a projected size of US$55.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$116.4 Million by the year 2027.
Select Competitors (Total 25 Featured):
- Astellas Institute of Regenerative Medicine
- Asterias Biotherapeutics, Inc.
- BD Biosciences
- Cell Cure Neurosciences Ltd.
- Cellular Dynamics International
- GE Healthcare
- PerkinElmer, Inc.
- Reliance Life Sciences Ltd.
- Research & Diagnostics Systems, Inc.
- STEMCELL Technologies, Inc.
- Stemina Biomarker Discovery, Inc.
- Takara Bio, Inc.
- TATAA Biocenter AB
- Thermo Fischer Scientific Inc.
- UK Stem Cell Bank
- ViaCyte, Inc.
Frequently Asked Questions about the Global Market for Human Embryonic Stem Cell (hESC) Research
What is the estimated value of the Global Market for Human Embryonic Stem Cell (hESC) Research?
What is the growth rate of the Global Market for Human Embryonic Stem Cell (hESC) Research?
What is the forecasted size of the Global Market for Human Embryonic Stem Cell (hESC) Research?
Who are the key companies in the Global Market for Human Embryonic Stem Cell (hESC) Research?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- BD Biosciences
- GE Healthcare
- PerkinElmer, Inc.
- Takara Bio, Inc.
- TATAA Biocenter AB
- UK Stem Cell Bank
I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Astellas Institute of Regenerative Medicine
- Asterias Biotherapeutics, Inc.
- BD Biosciences
- Cell Cure Neurosciences Ltd.
- Cellular Dynamics International
- GE Healthcare
- PerkinElmer, Inc.
- Reliance Life Sciences Ltd.
- Research & Diagnostics Systems, Inc.
- STEMCELL Technologies, Inc.
- Stemina Biomarker Discovery, Inc.
- Takara Bio, Inc.
- TATAA Biocenter AB
- Thermo Fischer Scientific Inc.
- UK Stem Cell Bank
- ViaCyte, Inc.
Note: Product cover images may vary from those shown